ZTL-103

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameZTL-103
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesZelira Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZelira Therapeutics LtdSt. Vincent'S Hospital Melbourne
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A